Actively Recruiting
Surgery As Needed for Oesophageal Cancer - 2
Led by Bas P. L. Wijnhoven · Updated on 2024-02-20
360
Participants Needed
1
Research Sites
407 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective cohort study on active surveillance after neoadjuvant chemoradiation for oesophageal cancer: SANO-2 study.
CONDITIONS
Official Title
Surgery As Needed for Oesophageal Cancer - 2
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Operable patients planned to undergo or recently underwent neoadjuvant chemoradiotherapy according to CROSS followed by surgery for histologically proven oesophageal squamous cell carcinoma or adenocarcinoma of the oesophagus or oesophago-gastric junction
- Age 18 years or older
- Written, voluntary, informed consent
You will not qualify if you...
- Non-FDG-avid tumour at baseline PET-CT scan
- Initial treatment with endoscopic resection
- Patients who underwent or are planned to undergo definitive chemoradiotherapy
- Language difficulty, dementia, or altered mental status preventing understanding and informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasmus University Medical Center
Rotterdam, South Holland, Netherlands, 3015 GD
Actively Recruiting
Research Team
C
Charlène vd Zijden, Drs.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here